Nicotinamide Riboside (NR) Guide: NAD+ Precursor B…

Nicotinamide riboside (NR) has a legitimate claim to being the most researched NAD+ precursor in humans. ChromaDex, the company behind the Tru Niagen brand, has funded a substantial body of clinical research — more than a dozen published human trials. That makes NR unusual in the supplement world, where human data is often thin.

But more research doesn't mean more certainty. Here's a clear-eyed look at what NR does, what it doesn't do, and one metabolic interaction that most people taking it don't know about.

What NR does in the body

NR is one step closer to NAD+ than NMN in the biosynthetic pathway. After absorption, NR is phosphorylated to NMN, which is then converted to NAD+. It's efficiently absorbed orally, which is a practical advantage over some other NAD+ precursors.

NAD+ itself powers the electron transport chain in mitochondria, serves as a substrate for sirtuins (SIRT1-7, proteins implicated in longevity and stress response), and fuels PARP enzymes involved in DNA repair.

The human trial data

ChromaDex/Tru Niagen trials: Multiple published trials confirm that NR consistently raises blood NAD+ levels. A 2018 trial in Nature Communications showed dose-dependent NAD+ increases in healthy adults at 100mg, 300mg, and 1000mg/day. No serious adverse events were reported.

A 2020 trial (University of Washington) in older adults found that 500mg twice daily raised NAD+ but did not improve physical performance, blood pressure, or other metabolic markers over 6 weeks. Raising NAD+ is not the same as producing clinical benefit.

Cardiovascular trials: A small trial at the University of Colorado found that NR at 1000mg/day improved arterial stiffness in older adults with mildly elevated blood pressure — a meaningful result, though the study was not large.

Skeletal muscle data: Some trials show increased NAD+ in muscle tissue specifically, which is relevant because muscle is highly metabolically active and NAD+ depletion there has functional consequences.

The overall picture: NR reliably raises NAD+. Whether that translates to meaningful longevity or health outcomes remains incompletely demonstrated.

Sirtuins, PARP, and the competition problem

This is where it gets nuanced. NAD+ fuels both sirtuins (longevity-associated proteins) and PARP enzymes (DNA repair). When DNA damage is high — from UV, toxins, or oxidative stress — PARP activity can consume large amounts of NAD+, leaving little for sirtuins.

Supplementing NR may boost the pool available to both pathways. But there's a less-discussed issue: at high doses, NR and NAD+ metabolism places significant demand on methylation.

The final metabolic product of NAD+ catabolism is methylnicotinamide, which requires a methyl group from SAM (S-adenosylmethionine). If you're cycling through large amounts of NAD+, you can deplete methyl groups — with downstream effects on mood, homocysteine levels, and other methylation-dependent processes.

Practical implication: If you're taking 500mg/day or more of NR (or NMN), consider pairing it with methylfolate (5-MTHF) and methylcobalamin (B12) to support methylation. This is particularly relevant for people with MTHFR variants who already have compromised methylation capacity.

Dosage

Doses studied in human trials range from 100mg to 1000mg/day. The most commonly used dose is 300-500mg/day.

300mg/day: raises NAD+ meaningfully with minimal metabolic burden
500mg twice daily: used in several university trials; stronger NAD+ elevation
1000mg/day: maximally studied dose; more methyl group demand; some GI discomfort reported

There is no established "optimal" dose for longevity outcomes because those outcomes haven't been measured in long-term trials.

NR vs. NMN: which is better?

Both raise NAD+. Both have human trial data. The key differences:

NR has more published human trials overall
NMN has some evidence for faster absorption via a dedicated transporter (SLIT2)
Bioavailability is comparable for most forms when taken orally
Cost: NMN is generally more expensive per milligram

The honest answer is that no head-to-head trial has demonstrated one is clinically superior. If budget matters, NR may offer more research backing per dollar.

Longevity pathways: what we know

NR activates sirtuins by increasing NAD+ availability. Sirtuins regulate gene expression, mitochondrial function, and stress response in ways linked to longevity in model organisms. In yeast, worms, flies, and mice, sirtuin activation extends lifespan under certain conditions.

In humans, we don't have lifespan data. What we have is mechanistic plausibility and metabolic surrogate markers. That's worth something — but it's not proof.

The bottom line

NR is one of the better-studied longevity supplements on the market, with a clear mechanism and consistent human pharmacokinetic data. The evidence for meaningful health outcomes beyond NAD+ elevation is real but incomplete.

If you take NR at 300-500mg/day, you will likely raise your NAD+ levels. You may see metabolic benefits, particularly if you're older or have metabolic dysfunction. Pair it with methylfolate and B12 if you're using higher doses or have MTHFR concerns.

Track your energy, sleep, and markers over time to see if NR is actually moving the needle for you. Use Optimize free.

Nicotinamide Riboside (NR) Guide: NAD+ Precursor Benefits and Dosing